A phase II/III trial of bitopertin monotherapy compared with placebo in patients with an acute exacerbation of schizophrenia–results from the CandleLyte study - Bugarski-Kirola, D; Wang, A; Abi-Saab, D (European Neuropsychopharmacology, 2014)
et al.